Huang Lu, Pu Chao, Fisher Richard K, Mountain Deidra J H, Gao Yanfei, Liaw Peter K, Zhang Wei, He Wei
Department of Materials Science and Engineering, The University of Tennessee, Knoxville, TN 37996-2100, USA.
Department of Surgery, The University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA.
Acta Biomater. 2015 Oct;25:356-68. doi: 10.1016/j.actbio.2015.07.012. Epub 2015 Jul 7.
Despite the prevalent use of crystalline alloys in current vascular stent technology, new biomaterials are being actively sought after to improve stent performance. In this study, we demonstrated the potential of a Zr-Al-Fe-Cu bulk metallic glass (BMG) to serve as a candidate stent material. The mechanical properties of the Zr-based BMG, determined under both static and cyclic loadings, were characterized by high strength, which would allow for the design of thinner stent struts to improve stent biocompatibility. Finite element analysis further complemented the experimental results and revealed that a stent made of the Zr-based BMG was more compliant with the beats of a blood vessel, compared with medical 316L stainless steel. The Zr-based BMG was found to be corrosion resistant in a simulated body environment, owing to the presence of a highly stable ZrO2-rich surface passive film. Application-specific biocompatibility studies were conducted using human aortic endothelial cells and smooth muscle cells. The Zr-Al-Fe-Cu BMG was found to support stronger adhesion and faster coverage of endothelial cells and slower growth of smooth muscle cells than 316L stainless steel. These results suggest that the Zr-based BMG could promote re-endothelialization and potentially lower the risk of restenosis, which are critical to improve vascular stent implantation integration. In general, findings in this study raised the curtain for the potential application of BMGs as future candidates for stent applications.
Vascular stents are medical devices typically used to restore the lumen of narrowed or clogged blood vessel. Despite the clinical success of metallic materials in stent-assisted angioplasty, post-surgery complications persist due to the mechanical failures, corrosion, and in-stent restenosis of current stents. To overcome these hurdles, strategies including new designs and surface functionalization have been exercised. In addition, the development of new materials with higher performance and biocompatibility can intrinsically reduce stent failure rates. The present study demonstrates the advantages of a novel material, named bulk metallic glass (BMG), over the benchmarked 316L stainless steel through experimental methods and computational simulations. It raises the curtain of new research endeavors on BMGs as competitive alternatives for stent applications.
尽管目前血管支架技术中普遍使用晶态合金,但人们仍在积极寻找新型生物材料以改善支架性能。在本研究中,我们展示了锆-铝-铁-铜块体金属玻璃(BMG)作为候选支架材料的潜力。在静态和循环载荷下测定的锆基BMG的力学性能表现为高强度,这使得可以设计更薄的支架支柱以提高支架的生物相容性。有限元分析进一步补充了实验结果,并表明与医用316L不锈钢相比,由锆基BMG制成的支架与血管搏动更贴合。由于存在高度稳定的富含ZrO₂的表面钝化膜,发现锆基BMG在模拟人体环境中具有耐腐蚀性。使用人主动脉内皮细胞和平滑肌细胞进行了特定应用的生物相容性研究。结果发现,与316L不锈钢相比,Zr-Al-Fe-Cu BMG能支持内皮细胞更强的黏附、更快的覆盖以及平滑肌细胞更缓慢的生长。这些结果表明,锆基BMG可促进再内皮化并可能降低再狭窄风险,这对于改善血管支架植入整合至关重要。总体而言,本研究的结果为BMG作为未来支架应用候选材料的潜在应用拉开了序幕。
血管支架是一种医疗设备,通常用于恢复狭窄或堵塞血管的管腔。尽管金属材料在支架辅助血管成形术中取得了临床成功,但由于当前支架的机械故障、腐蚀和支架内再狭窄,术后并发症仍然存在。为克服这些障碍,人们采取了包括新设计和表面功能化在内的策略。此外,开发具有更高性能和生物相容性的新材料可从本质上降低支架故障率。本研究通过实验方法和计算模拟证明了一种名为块体金属玻璃(BMG)的新型材料相对于基准316L不锈钢的优势。它为BMG作为支架应用的有竞争力的替代材料的新研究努力拉开了序幕。